HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
-11.58%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.71B
AUM Growth
+$1.71B
(-2.8%)
Cap. Flow
+$199M
Cap. Flow
% of AUM
11.62%
Top 10 Holdings %
Top 10 Hldgs %
55.06%
Holding
64
New
15
Increased
15
Reduced
10
Closed
20
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$122M |
| 2 |
SRCL
Stericycle Inc
SRCL
|
$108M |
| 3 |
Pfizer
PFE
|
$84M |
| 4 |
Eli Lilly
LLY
|
$83.7M |
| 5 |
Abbott
ABT
|
$81.3M |
Top Sells
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$115M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$111M |
| 3 |
HCA Healthcare
HCA
|
$60M |
| 4 |
Cigna
CI
|
$52.7M |
| 5 |
Danaher
DHR
|
$51.4M |
Sector Composition
| 1 | Healthcare | 63.69% |
| 2 | Industrials | 6.31% |
| 3 | Financials | 4.16% |
| 4 | Real Estate | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $129M | 7.27% | 475,000 +447,490 | +1,627% | +$122M |
|
2
Edwards Lifesciences
EW
$47.8B
| $110M | 6.2% | 775,000 -325,000 | -30% | -$46.2M |
|
|
SRCL
3
DELISTED
Stericycle Inc
SRCL
| $108M | 6.08% | +775,000 | New | +$108M |
|
|
BCR
4
DELISTED
CR Bard Inc.
BCR
| $102M | 5.77% | 550,000 +75,000 | +16% | +$14M |
|
|
5
Abbott
ABT
$231B
| $90.5M | 5.09% | 2,250,000 +2,020,170 | +879% | +$81.3M |
|
|
6
Pfizer
PFE
$141B
| $84M | 4.73% | +2,675,000 | New | +$84M |
|
|
7
Eli Lilly
LLY
$657B
| $83.7M | 4.71% | +1,000,000 | New | +$83.7M |
|
|
RAD
8
DELISTED
Rite Aid Corporation
RAD
| $82.1M | 4.62% | 13,525,000 +1,525,000 | +13% | +$9.26M |
|
|
MDVN
9
DELISTED
MEDIVATION, INC.
MDVN
| $80.8M | 4.55% | 1,900,000 +1,200,000 | +171% | +$51M |
|
|
AET
10
DELISTED
Aetna Inc
AET
| $71.1M | 4% | 650,000 -175,000 | -21% | -$19.1M |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $70.4M | 3.96% | +450,000 | New | +$70.4M |
|
12
Vertex Pharmaceuticals
VRTX
$100B
| $67.7M | 3.81% | 650,000 +200,000 | +44% | +$20.8M |
|
|
AKRX
13
DELISTED
Akorn, Inc.
AKRX
| $66.3M | 3.73% | 2,325,000 +600,000 | +35% | +$17.1M |
|
14
Labcorp
LH
$23.1B
| $59.7M | 3.36% | 550,000 +200,000 | +57% | +$21.7M |
|
15
Universal Health Services
UHS
$11.6B
| $59.3M | 3.34% | 475,000 +460,100 | +3,088% | +$57.4M |
|
|
CVRS
16
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $53.9M | 3.03% | 19,981,655 | – | – |
|
17
McKesson
MCK
$85.4B
| $50.9M | 2.86% | +275,000 | New | +$50.9M |
|
|
18
HCA Healthcare
HCA
$94.5B
| $44.5M | 2.5% | 575,000 -775,000 | -57% | -$60M |
|
19
Brookdale Senior Living
BKD
$1.83B
| $44.2M | 2.49% | 1,925,000 -925,000 | -32% | -$21.2M |
|
|
TMH
20
DELISTED
Team Health Holdings Inc
TMH
| $24.3M | 1.37% | +450,000 | New | +$24.3M |
|
21
Acadia Pharmaceuticals
ACAD
$4.38B
| $22.4M | 1.26% | 678,700 -146,300 | -18% | -$4.84M |
|
22
United Therapeutics
UTHR
$13.8B
| $22.4M | 1.26% | +170,400 | New | +$22.4M |
|
23
Collegium Pharmaceutical
COLL
$1.22B
| $21M | 1.18% | 950,000 +476,336 | +101% | +$10.5M |
|
|
ALR
24
DELISTED
Alere Inc
ALR
| $19.3M | 1.08% | 400,000 -325,000 | -45% | -$15.6M |
|
|
SGNT
25
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $19.2M | 1.08% | 1,250,000 +337,619 | +37% | +$5.18M |
|